Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for prevention of emergence agitation after pediatric tonsillectomy and adenoidectomy
ChiCTR2000029340Phase 4Recruiting
- Sponsor
- Foshan First People's Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine in Emergence agitation (EA) and postoperative pain (2 arms), sponsored by Foshan First People's Hospital. Primary endpoints: PAED score and Pain intensity. Started Jan 2020; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
Emergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on ChiCTR2000029340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029340.